BioAlliance Pharma Submits a Phase III Clinical Trial Application for Livatag

BioAlliance Pharma SA, a company dedicated to specialty and orphan oncology products, today announced the submission of a Phase III clinical trial application for Livatag in the treatment of primary liver cancer to the French Drug Agency.
Business Wire